Found: 1
Select item for more details and to access through your institution.
Open-label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article